Summary of Product Characteristics
last updated on the eMC:
08/02/2010
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 08/02/2010 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 5.1 - Pharmacodynamic Properties
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 22-Dec-2009 |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
|
Section 5.1
Addition of paragraph:
In a double-blind, saline solution (Otrisal) controlled study in patients with common cold, the decongestant effect of Otrivine was significantly superior (p<0.0001) to Otrisal saline solution based on rhinomanometry measurement at 1 hour after administration of the study drugs.
Section 10
Date change from 14 October 2003 to 22 December 2009
|
|
Updated on 31/10/2007 and displayed until 08/02/2010
|
Reasons for adding or updating:
|
-
Change to separate SPCs covering individual presentations
|
| Date of revision of text on the SPC: 10/2003 |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Change to separate SPCs covering individual presentations
|
|
Updated on 19/09/2002 and displayed until 31/10/2007
|
Reasons for adding or updating:
|
-
Change to section 6.1 - List of Excipients
-
Change to section 6. 3 - Shelf Life
|
|
Updated on 14/08/2001 and displayed until 19/09/2002
|
Reasons for adding or updating:
|
-
Addition of joint SPC covering all presentations
|
|